CT
Cognition Therapeutics Inc
🇺🇸XNAS.CGTXUnited StatesHealthcare
$1.02USDdown -0.02 (-1.92%)ClosedEnd of day1:25 AM
Price$1.02-0.02 (-1.92%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US19243B1026
- CUSIP
- 19243B102
Company
- Employees
- 14
- Headquarters
- Purchase, United States
- Website
- https://www.cogrx.com
- CEO
- Ms. Lisa Ricciardi
Market
- Shares outstanding
- 95.1M
- Market cap
- $97M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $98.9M
- EPS LTM
- -$0.18calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -5.78calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$16.78M+49.16%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$17.7M+42.4%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.